Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cancer Discov ; 11(11): 2796-2811, 2021 11.
Artigo em Inglês | MEDLINE | ID: mdl-34183353

RESUMO

AURORA aims to study the processes of relapse in metastatic breast cancer (MBC) by performing multi-omics profiling on paired primary tumors and early-course metastases. Among 381 patients (primary tumor and metastasis pairs: 252 targeted gene sequencing, 152 RNA sequencing, 67 single nucleotide polymorphism arrays), we found a driver role for GATA1 and MEN1 somatic mutations. Metastases were enriched in ESR1, PTEN, CDH1, PIK3CA, and RB1 mutations; MDM4 and MYC amplifications; and ARID1A deletions. An increase in clonality was observed in driver genes such as ERBB2 and RB1. Intrinsic subtype switching occurred in 36% of cases. Luminal A/B to HER2-enriched switching was associated with TP53 and/or PIK3CA mutations. Metastases had lower immune score and increased immune-permissive cells. High tumor mutational burden correlated to shorter time to relapse in HR+/HER2- cancers. ESCAT tier I/II alterations were detected in 51% of patients and matched therapy was used in 7%. Integration of multi-omics analyses in clinical practice could affect treatment strategies in MBC. SIGNIFICANCE: The AURORA program, through the genomic and transcriptomic analyses of matched primary and metastatic samples from 381 patients with breast cancer, coupled with prospectively collected clinical data, identified genomic alterations enriched in metastases and prognostic biomarkers. ESCAT tier I/II alterations were detected in more than half of the patients.This article is highlighted in the In This Issue feature, p. 2659.


Assuntos
Neoplasias da Mama , Biomarcadores Tumorais/genética , Neoplasias da Mama/diagnóstico , Neoplasias da Mama/tratamento farmacológico , Neoplasias da Mama/genética , Proteínas de Ciclo Celular/genética , Detecção Precoce de Câncer , Feminino , Genômica , Sequenciamento de Nucleotídeos em Larga Escala , Humanos , Mutação , Recidiva Local de Neoplasia/patologia , Proteínas Proto-Oncogênicas/genética , Transcriptoma
2.
Int J Mol Sci ; 14(11): 22117-31, 2013 Nov 08.
Artigo em Inglês | MEDLINE | ID: mdl-24217225

RESUMO

Ribonucleoprotein complexes are essential regulatory components in bacteria. In this review, we focus on the carbon storage regulator (Csr) network, which is well conserved in the bacterial world. This regulatory network is composed of the CsrA master regulator, its targets and regulators. CsrA binds to mRNA targets and regulates translation either negatively or positively. Binding to small non-coding RNAs controls activity of this protein. Expression of these regulators is tightly regulated at the level of transcription and stability by various global regulators (RNAses, two-component systems, alarmone). We discuss the implications of these complex regulations in bacterial adaptation.


Assuntos
Adaptação Biológica , Carbono/metabolismo , Proteínas de Choque Térmico/genética , Ribonucleoproteínas/genética , Receptores Depuradores Classe A/genética , Proteínas de Bactérias/genética , Escherichia coli/genética , Escherichia coli/fisiologia , Proteínas de Escherichia coli/genética , Redes Reguladoras de Genes , Proteínas de Choque Térmico/metabolismo , Humanos , RNA Mensageiro/genética , RNA não Traduzido/genética , RNA não Traduzido/metabolismo , Proteínas de Ligação a RNA/genética , Proteínas de Ligação a RNA/metabolismo , Proteínas Repressoras/genética , Ribonucleoproteínas/metabolismo , Receptores Depuradores Classe A/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...